Dr Nnenna Elebo, obtained her MSc and PhD from the University of the Witwatersrand in 2022. Her focus is on hepatopancreatobiliary cancers, specifically pancreatic, with a special emphasis on their impact on disadvantaged groups like African populations. Her current work involves studies on immune metabolism to identify biomarkers for early detection and improving the understanding, treatment, and management of these cancers.